Medical Science Liaison, Oncology, Lung & GU Tumors North Texas

Join to apply for the Medical Science Liaison, Oncology, Lung & GU Tumors (Central & North Texas) role at Bristol Myers Squibb

Challenging. Meaningful. Life‑changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high‑achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more:  .

Medical Science Liaison, Oncology, Lung & GU Tumors

Central & North Texas / Oklahoma

• Develop trusted relationships with appropriate academic and community Thought Leaders (TLs) in Oncology through high‑quality peer‑to‑peer scientific dialogue in both proactive and reactive settings.
• Effectively collaborate and engage in scientific dialogue with TLs to gain insights on clinical landscape to ensure development of a medical plan that is both product/disease area focused and translates into effective launch.
• Proactively engage in scientific and clinical conversation to ensure development of a medical plan that is both product/disease area focused and translates into effective launch and LCM activities.
• Engage with medical societies, PAGs (Patient Advocacy Groups) and guideline committee members as appropriate.
• Provide training for external speakers as needed.
• Strategically engage payers in the pre‑ and peri‑launch phases (with fHEOR and Account Executives).
• Provide medical support to address unsolicited HCP questions in real‑time, both in face‑to‑face interactions and through the Medical on Call virtual capability.
• Develop credible connections with key Thought Leaders (TLs) in oncology through high‑quality peer‑to‑peer scientific dialogue.
• Appropriately document and achieve annual goals.
• Leverage digital capabilities to enhance medical engagement.
• Provide recommendations and insights to clinical development team on study feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators.
• Liaise with key large accounts to understand clinical barriers to patient access and ensuring equity in access to clinical trials.
• Lead major evidence read‑outs with clinical trial investigators (e.g., Phase 3 top‑line data).
• Support Interventional and Non‑Interventional Research (NIR) studies (e.g., identification and assessment of potential study sites) to facilitate patient recruitment and/or discussions around the safe and effective use of BMS investigational products.
• Support HCPs in the ISR submission and execution process and study follow‑up as agreed upon with home office medical and GDO.
• Ensure that BMS Pharmacovigilance procedural documents are understood and applied by investigators of local studies, and alert appropriate BMS personnel to any identified adverse events.
• If applicable, support CRO sponsored studies as agreed with home office medical and GDO and as defined by the study scope document.

• MD, Pharm
  
  D, PhD, APP, PA, NP with experience in a specific Disease Area or with a broad medical background or relevant pharmaceutical experience.
• Working in a scientific and/or clinical research environment. Field medical expertise preferred.
• Deep understanding of TL environment and needs.

• Scientific or clinical disease area knowledge, patient treatment trends, clinical landscape.
• Pharmaceutical industry including compliance and regulatory guidelines.

• Clinical trial design and process.
• Understanding of national and regional healthcare and…